OraSure Technologies (OSUR) Competitors $2.55 -0.25 (-8.93%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$2.61 +0.06 (+2.31%) As of 05/21/2025 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OSUR vs. CERS, UTMD, ANIK, COO, WST, ALGN, MMSI, ICUI, HAE, and XRAYShould you be buying OraSure Technologies stock or one of its competitors? The main competitors of OraSure Technologies include Cerus (CERS), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), Cooper Companies (COO), West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), and DENTSPLY SIRONA (XRAY). These companies are all part of the "health care supplies" industry. OraSure Technologies vs. Cerus Utah Medical Products Anika Therapeutics Cooper Companies West Pharmaceutical Services Align Technology Merit Medical Systems ICU Medical Haemonetics DENTSPLY SIRONA Cerus (NASDAQ:CERS) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, community ranking, dividends, valuation, analyst recommendations, profitability, media sentiment and risk. Does the MarketBeat Community believe in CERS or OSUR? Cerus received 17 more outperform votes than OraSure Technologies when rated by MarketBeat users. Likewise, 72.34% of users gave Cerus an outperform vote while only 68.87% of users gave OraSure Technologies an outperform vote. CompanyUnderperformOutperformCerusOutperform Votes57072.34% Underperform Votes21827.66% OraSure TechnologiesOutperform Votes55368.87% Underperform Votes25031.13% Which has more risk and volatility, CERS or OSUR? Cerus has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500. Comparatively, OraSure Technologies has a beta of 0.42, meaning that its share price is 58% less volatile than the S&P 500. Is CERS or OSUR more profitable? OraSure Technologies has a net margin of 5.07% compared to Cerus' net margin of -11.60%. OraSure Technologies' return on equity of 3.55% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Cerus-11.60% -40.55% -11.12% OraSure Technologies 5.07%3.55%3.23% Which has stronger earnings & valuation, CERS or OSUR? OraSure Technologies has lower revenue, but higher earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCerus$185.14M1.29-$37.49M-$0.10-12.50OraSure Technologies$161.63M1.18$53.65M-$0.42-6.07 Do institutionals and insiders hold more shares of CERS or OSUR? 78.4% of Cerus shares are owned by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are owned by institutional investors. 3.4% of Cerus shares are owned by insiders. Comparatively, 3.9% of OraSure Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media refer more to CERS or OSUR? In the previous week, OraSure Technologies had 11 more articles in the media than Cerus. MarketBeat recorded 13 mentions for OraSure Technologies and 2 mentions for Cerus. Cerus' average media sentiment score of 0.84 beat OraSure Technologies' score of 0.57 indicating that Cerus is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cerus 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OraSure Technologies 5 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate CERS or OSUR? Cerus presently has a consensus price target of $3.50, indicating a potential upside of 180.00%. OraSure Technologies has a consensus price target of $3.00, indicating a potential upside of 17.65%. Given Cerus' stronger consensus rating and higher possible upside, equities analysts plainly believe Cerus is more favorable than OraSure Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00OraSure Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryCerus beats OraSure Technologies on 10 of the 18 factors compared between the two stocks. Get OraSure Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for OSUR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OSUR vs. The Competition Export to ExcelMetricOraSure TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$190.74M$4.49B$5.37B$8.39BDividend YieldN/A43.63%5.22%4.10%P/E Ratio17.0029.4326.8419.71Price / Sales1.1867.72392.34117.39Price / Cash2.8951.0838.2534.62Price / Book0.446.236.794.50Net Income$53.65M$68.16M$3.23B$248.18M7 Day Performance3.66%-0.19%1.53%0.20%1 Month Performance-13.85%19.19%10.05%12.37%1 Year Performance-49.50%21.47%16.71%7.04% OraSure Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OSUROraSure Technologies4.0302 of 5 stars$2.55-8.9%$3.00+17.6%-48.0%$190.74M$161.63M17.00840Analyst ForecastCERSCerus2.8923 of 5 stars$1.35+4.7%$3.50+159.3%-32.4%$258.07M$185.14M-12.27290Positive NewsGap UpUTMDUtah Medical Products2.1588 of 5 stars$54.02+0.8%N/A-22.4%$177.29M$39.27M13.68180Positive NewsDividend AnnouncementANIKAnika Therapeutics4.1355 of 5 stars$11.85+1.8%$21.33+80.0%-54.5%$169.94M$119.91M-1.78300Gap UpCOOCooper Companies3.1303 of 5 stars$84.44+2.6%$110.25+30.6%-18.0%$16.89B$3.93B43.3014,000Positive NewsAnalyst UpgradeWSTWest Pharmaceutical Services4.5697 of 5 stars$219.20+2.9%$332.50+51.7%-38.0%$15.75B$2.90B32.7710,700Trending NewsAnalyst RevisionALGNAlign Technology4.7819 of 5 stars$189.00+3.9%$241.25+27.6%-34.9%$13.84B$3.98B33.6923,200Positive NewsMMSIMerit Medical Systems4.1455 of 5 stars$98.73+3.0%$107.78+9.2%+17.2%$5.83B$1.39B48.406,850Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionICUIICU Medical4.7589 of 5 stars$144.34+4.4%$192.67+33.5%+27.3%$3.55B$2.38B-31.5814,500Analyst UpgradeInsider TradeGap UpHAEHaemonetics4.3176 of 5 stars$70.23+3.0%$97.89+39.4%-28.2%$3.53B$1.36B27.652,820Analyst ForecastGap UpXRAYDENTSPLY SIRONA4.9515 of 5 stars$16.75+5.9%$20.36+21.6%-43.9%$3.34B$3.72B-8.0915,000 Related Companies and Tools Related Companies Cerus Competitors Utah Medical Products Competitors Anika Therapeutics Competitors Cooper Companies Competitors West Pharmaceutical Services Competitors Align Technology Competitors Merit Medical Systems Competitors ICU Medical Competitors Haemonetics Competitors DENTSPLY SIRONA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OSUR) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OraSure Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OraSure Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.